Literature DB >> 26254317

Preferences for Aftercare Among Persons Seeking Short-Term Opioid Detoxification.

Michael D Stein1, Bradley J Anderson2, Genie L Bailey3.   

Abstract

Without aftercare treatment, the period following discharge from short-term inpatient detoxification for opioid dependence presents a high risk of relapse. Yet the role of patient preference in treatment selection is rarely discussed in the substance-abuse literature. We surveyed 485 persons initiating inpatient opioid detoxification who were predominantly male (71.3%) and had detoxed in the past (73.2%). When asked to choose the one treatment that would work best for them after discharge, 43% of participants selected medication-assisted treatment (MAT), 29% preferred residential, 12% selected drug-free counseling, 12% NA/AA meetings only, and 4% preferred no additional treatment. Residential treatment preference was significantly associated with homelessness, having been in a detox program within the past year, and having pending legal problems, indicating that there is a distinct profile of detox patients who prefer residential treatment despite its limited availability. Detox program staff should work with patients to understand reasons for treatment preferences to optimize aftercare services.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aftercare; Detoxification; Opioid; Residential treatment

Mesh:

Year:  2015        PMID: 26254317      PMCID: PMC4661074          DOI: 10.1016/j.jsat.2015.07.002

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  47 in total

1.  Treatment retention and 1 year outcomes for residential programmes in England.

Authors:  M Gossop; J Marsden; D Stewart; A Rolfe
Journal:  Drug Alcohol Depend       Date:  1999-12-01       Impact factor: 4.492

2.  One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).

Authors:  Maree Teesson; Joanne Ross; Shane Darke; Michael Lynskey; Robert Ali; Alison Ritter; Richard Cooke
Journal:  Drug Alcohol Depend       Date:  2005-12-15       Impact factor: 4.492

3.  Factors associated with frequent utilization of crisis substance use detoxification services.

Authors:  Emily Carrier; Jennifer McNeely; Iryna Lobach; Shane Tay; Marc N Gourevitch; Maria C Raven
Journal:  J Addict Dis       Date:  2011-04

4.  Evidence on the Chronic Care Model in the new millennium.

Authors:  Katie Coleman; Brian T Austin; Cindy Brach; Edward H Wagner
Journal:  Health Aff (Millwood)       Date:  2009 Jan-Feb       Impact factor: 6.301

5.  Treating opioid use under California's Proposition 36: differential outcomes by treatment modality.

Authors:  Bradley T Conner; Ashley S Hampton; Jeremy Hunter; Darren Urada
Journal:  J Psychoactive Drugs       Date:  2011-09

Review 6.  Are detoxification programmes effective?

Authors:  R P Mattick; W Hall
Journal:  Lancet       Date:  1996-01-13       Impact factor: 79.321

7.  Regional brain metabolic activation during craving elicited by recall of previous drug experiences.

Authors:  G J Wang; N D Volkow; J S Fowler; P Cervany; R J Hitzemann; N R Pappas; C T Wong; C Felder
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

8.  Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.

Authors:  Evgeny Krupitsky; Edward V Nunes; Walter Ling; Ari Illeperuma; David R Gastfriend; Bernard L Silverman
Journal:  Lancet       Date:  2011-04-30       Impact factor: 79.321

9.  An examination of the cocaine relapse process.

Authors:  J R McKay; M J Rutherford; A I Alterman; J S Cacciola; M R Kaplan
Journal:  Drug Alcohol Depend       Date:  1995-04       Impact factor: 4.492

10.  Trends in inpatient detoxification services, 1992-1997.

Authors:  Tami L Mark; Joan D Dilonardo; Mady Chalk; Rosanna M Coffey
Journal:  J Subst Abuse Treat       Date:  2002-12
View more
  14 in total

1.  Attitudes about medications for alcohol use disorder among individuals with serious mental illness: A health belief model analysis.

Authors:  Elizabeth Bromley; Derjung M Tarn; Michael McCreary; Brian Hurley; Allison J Ober; Katherine E Watkins
Journal:  J Subst Abuse Treat       Date:  2020-04-20

2.  The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use.

Authors:  Andrew S Huhn; D Andrew Tompkins; Kelly E Dunn
Journal:  Drug Alcohol Depend       Date:  2017-09-09       Impact factor: 4.492

3.  Overdose history is associated with postdetoxification treatment preference for persons with opioid use disorder.

Authors:  Michael D Stein; Jessica N Flori; Megan M Risi; Micah T Conti; Bradley J Anderson; Genie L Bailey
Journal:  Subst Abus       Date:  2017-07-10       Impact factor: 3.716

4.  Recovery Goals and Long-term Treatment Preference in Persons Who Engage in Nonmedical Opioid Use.

Authors:  Kaitlyn R Hay; Andrew S Huhn; David Andrew Tompkins; Kelly E Dunn
Journal:  J Addict Med       Date:  2019 Jul/Aug       Impact factor: 3.702

5.  Perceived need for depression treatment among persons entering inpatient opioid detoxification.

Authors:  Michael D Stein; Olga J Santiago Rivera; Bradley J Anderson; Genie L Bailey
Journal:  Am J Addict       Date:  2017-04-28

6.  NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale.

Authors:  Joshua D Lee; Edward V Nunes; Patricia Novo Mpa; Genie L Bailey; Gregory S Brigham; Allan J Cohen; Marc Fishman; Walter Ling; Robert Lindblad; Dikla Shmueli-Blumberg; Don Stablein; Jeanine May; Dagmar Salazar; David Liu; John Rotrosen
Journal:  Contemp Clin Trials       Date:  2016-08-10       Impact factor: 2.226

7.  Association between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: a cohort analysis.

Authors:  Alexander Y Walley; Sara Lodi; Yijing Li; Dana Bernson; Hermik Babakhanlou-Chase; Thomas Land; Marc R Larochelle
Journal:  Addiction       Date:  2020-02-25       Impact factor: 6.526

8.  A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder.

Authors:  Maria A Sullivan; Adam Bisaga; Martina Pavlicova; Kenneth M Carpenter; C Jean Choi; Kaitlyn Mishlen; Frances R Levin; John J Mariani; Edward V Nunes
Journal:  Am J Psychiatry       Date:  2018-10-19       Impact factor: 18.112

9.  Touchpoints - Opportunities to predict and prevent opioid overdose: A cohort study.

Authors:  Marc R Larochelle; Ryan Bernstein; Dana Bernson; Thomas Land; Thomas J Stopka; Adam J Rose; Monica Bharel; Jane M Liebschutz; Alexander Y Walley
Journal:  Drug Alcohol Depend       Date:  2019-09-03       Impact factor: 4.492

10.  Negative affect-associated drug refusal self-efficacy, illicit opioid use, and medication use following short-term inpatient opioid withdrawal management.

Authors:  Jumi Hayaki; Micah T Conti; Genie L Bailey; Debra S Herman; Bradley J Anderson; Michael D Stein
Journal:  J Subst Abuse Treat       Date:  2021-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.